[The immunogenicity and impact factors of hepatitis A attenuated live vaccine and inactivated vaccine].
Hepatitis A is one of the global public health problems, and China has high prevalence. In order to decrease the incidence of hepatitis A, China has integrated Hepatitis A vaccine into Expanded Program on Immunization (EPI) in 2007. The paper will provide some ideas on the immunogenicity and impact factors of the different types of hepatitis A vaccines that are used in China.
Zheng
Hui
H
Department of National Immunization Programme, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Cui
Fu-Qiang
FQ
D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D002681:China; D006506:Hepatitis A / Q000276:immunology* / Q000517:prevention & control / Q000821:virology; D022362:Hepatitis A Vaccines / Q000008:administration & dosage / Q000276:immunology*; D017957:Hepatitis A Virus, Human / Q000276:immunology*; D006801:Humans; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000276:immunology
D000914:Antibodies, Viral; D022362:Hepatitis A Vaccines; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated